| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.003 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.004 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.005 |